|
|
| | NBD-557 Basic information |
| Product Name: | NBD-557 | | Synonyms: | NBD-557;N-(4-Bromophenyl)-N'-(2,2,6,6-tetramethylpiperidin-4-yl)oxalamide;NBD-557;NBD 557;NBD557;NBD 557;NBD557;Ethanediamide, N1-(4-bromophenyl)-N2-(2,2,6,6-tetramethyl-4-piperidinyl)-;NBD-55;HIV,NBD557,NBD 557,NBD-557,inhibit,Human immunodeficiency virus,Inhibitor | | CAS: | 333352-59-3 | | MF: | C17H24BrN3O2 | | MW: | 382.3 | | EINECS: | | | Product Categories: | | | Mol File: | 333352-59-3.mol |  |
| | NBD-557 Chemical Properties |
| density | 1.35 | | storage temp. | Store at -20°C | | solubility | DMSO : 10 mg/mL (26.16 mM; Need ultrasonic) | | form | Powder | | pka | 10.73±0.70(Predicted) | | color | White to off-white |
| | NBD-557 Usage And Synthesis |
| Uses | NBD-557 is a N-phenyl-N''-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamide analog, a novel class of human immunodeficiency virus type 1 (HIV-1) entry inhibitors that block the gp120-CD4 interaction, | | Uses | NBD-557 is a N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamide analog, a novel class of human immunodeficiency virus type 1 (HIV-1) entry inhibitors that block the gp120-CD4 interaction, |
| | NBD-557 Preparation Products And Raw materials |
|